Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NASVAC vs Pegylated Interferon in Chronic Hepatitis B
NCT01374308Phase 3Unknown
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ABX203 in Chronic Hepatitis B (CHB). Status: unknown.
02
Drugs
ABX203
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01374308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374308.